ConductScience.org, home

Paper32408522

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.

Marques IP and 6 others. J Clin Med, 2020. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. Papers, record 32408522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32408522

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.
PubMed
Journal
J Clin Med
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.72
iCite
Revised in PubMed
2020-09-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marques IPInes P
2Madeira MHMaria H
3Messias ALAna L
4Santos TTorcato
5Martinho ACAntónio C-V
6Figueira JJoão
7Cunha-Vaz JJosé

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
FITEC/CIT/2018/2Programa Operacional Temático Factores de CompetitividadePubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07417410Analysis of DR Progression to Identify Risks and Need for TreatmentBackground

Source ClinicalTrials.gov

Download CSV of trials

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132200833Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10.Ophthalmology2020https://conductscience.org/library/papers/32200833PubMed
22866759Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.Arch Ophthalmol1985https://conductscience.org/library/papers/2866759PubMed
325602634Topical nepafenec in eyes with noncentral diabetic macular edema.Retina2015https://conductscience.org/library/papers/25602634PubMed
426322834Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.Invest Ophthalmol Vis Sci2015https://conductscience.org/library/papers/26322834PubMed
524680929Phenotypes and biomarkers of diabetic retinopathy.Prog Retin Eye Res2014https://conductscience.org/library/papers/24680929PubMed
616936162Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.Diabetes Care2006https://conductscience.org/library/papers/16936162PubMed
732181799Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study.Invest Ophthalmol Vis Sci2020https://conductscience.org/library/papers/32181799PubMed
829699981Microaneurysm turnover is a predictor of diabetic retinopathy progression.Br J Ophthalmol2019https://conductscience.org/library/papers/29699981PubMed
923745006Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23745006PubMed
1023841106Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations.J Diabetes Res2013https://conductscience.org/library/papers/23841106PubMed
1131047568Agreement between OCT Leakage and Fluorescein Angiography to Identify Sites of Alteration of the Blood-Retinal Barrier in Diabetes.Ophthalmol Retina2017https://conductscience.org/library/papers/31047568PubMed
1220580421Diabetic retinopathy.Lancet2010https://conductscience.org/library/papers/20580421PubMed
1314769598Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.Arch Ophthalmol2004https://conductscience.org/library/papers/14769598PubMed
1416965491The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes.Acta Ophthalmol Scand2006https://conductscience.org/library/papers/16965491PubMed
1529268280Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Macular Edema (C-TRACER Study).Ophthalmic Res2018https://conductscience.org/library/papers/29268280PubMed
1621865671Improved automated screening of diabetic retinopathy.Ophthalmologica2011https://conductscience.org/library/papers/21865671PubMed
1730389750Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.Diabetes2019https://conductscience.org/library/papers/30389750PubMed
1824080704Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes.Ophthalmologica2013https://conductscience.org/library/papers/24080704PubMed
1923204247Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.Diabetes Care2013https://conductscience.org/library/papers/23204247PubMed
208628551Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum.Ophthalmology1996https://conductscience.org/library/papers/8628551PubMed

See all 21 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
40646245Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging.Eye (Lond)2025https://conductscience.org/library/papers/40646245PubMed
37959396Immune Mediators Profiles in the Aqueous Humor of Patients with Simple Diabetic Retinopathy.J Clin Med2023https://conductscience.org/library/papers/37959396PubMed
37082811DNA methyltransferase expression (DNMT1, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema response.Eur J Ophthalmol2023https://conductscience.org/library/papers/37082811PubMed
36495395Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study.Ophthalmol Ther2023https://conductscience.org/library/papers/36495395PubMed
35757010Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease.Front Neurosci2021https://conductscience.org/library/papers/35757010PubMed
35450182A new handheld fundus camera combined with visual artificial intelligence facilitates diabetic retinopathy screening.Int J Ophthalmol2022https://conductscience.org/library/papers/35450182PubMed
35158351Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study.Ophthalmologica2022https://conductscience.org/library/papers/35158351PubMed
34900835The role of Optical Coherence Tomography Angiography to detect early microvascular changes in Diabetic Retinopathy: a systematic review.J Diabetes Metab Disord2021https://conductscience.org/library/papers/34900835PubMed
34865186Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.Ophthalmol Ther2022https://conductscience.org/library/papers/34865186PubMed
34442470Characterization of Risk Profiles for Diabetic Retinopathy Progression.J Pers Med2021https://conductscience.org/library/papers/34442470PubMed
34442032Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus.J Clin Med2021https://conductscience.org/library/papers/34442032PubMed
34070479Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study.J Clin Med2021https://conductscience.org/library/papers/34070479PubMed
34063514Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study.J Clin Med2021https://conductscience.org/library/papers/34063514PubMed
33355147Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR.Br J Ophthalmol2022https://conductscience.org/library/papers/33355147PubMed
33158947Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study.Diabetes Care2021https://conductscience.org/library/papers/33158947PubMed
33025221Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.Acta Diabetol2021https://conductscience.org/library/papers/33025221PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GMCL164395PubTator's text mininghttps://conductscience.org/library/genes/64395

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32408522

GET https://conductscience.org/api/papers/v1/32408522/references?page=2